Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis

Clinical trial NCT01456780 · COMPLETED

Trial details

NCT number: NCT01456780
Sponsor: Massachusetts Eye and Ear Infirmary
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Meibomian Gland Dysfunction Posterior Blepharitis

Start date: 2011-08-01
Primary completion: 2013-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.